⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for fluzoparib combined with apatinib

Every month we try and update this database with for fluzoparib combined with apatinib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Trial of SHR3162 Combined With Apatinib Mesylate Tablets or SHR3162 Monotherapy in Patients With Metastatic Castration Resistant Prostate CancerNCT04869488
Metastatic Cast...
Fluzoparib
Enzalutamide OR...
Fluzoparib Comb...
18 Years - Jiangsu HengRui Medicine Co., Ltd.
Treatment of Carrying TP53 Harmful MutationsNCT03645200
Advanced Cancer
Fluzoparib comb...
18 Years - 70 YearsTianjin Medical University Second Hospital
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: